AtriCure reported a significant increase in revenue for Q2 2021, driven by strong underlying demand and progress in establishing its platforms as standard of care. The company saw revenue growth in both the U.S. and international markets, reflecting the receding impact of the COVID-19 pandemic and increased demand.
Revenue for the second quarter of 2021 was $71.4 million, an increase of 74.8% over the second quarter of 2020.
U.S. revenue was $60.1 million, an increase of 78.4% compared to the second quarter of 2020.
International revenue increased 57.9% to $11.3 million.
The company is updating revenue guidance for full year 2021 to a range of $270 to $275 million.
Management is updating revenue guidance for full year 2021 to a range of $270 to $275 million and updating guidance for an adjusted loss per share of approximately $1.20.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance